Deciphex provides digital pathology solutions that leverage AI to enhance pathology service delivery and improve diagnostic turnaround times.

Deciphex

Deciphex is focused on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.

The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload.

We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.



Claret Capital Partners

Act Venture Capital

GI Partners

Irrus Investments

Enterprise Ireland

NextSteps Capital

Seroba Life Sciences

Halo Business Angel Network

HBAN Medtech Syndicate

Charles River Laboratories International

Novartis

Inova Personalized Health Accelerator

The Patholytix Data Capture Module is a game-changer for non-clinical study reviews, enabling users to review and score studies on a single platform for the first time. Its dynamic workflows for glass, digital, and hybrid studies, real-time data sync capabilities, geolocated findings, and flexible scoring templates accelerate critical decisions in drug safety assessment.

Watch our webinar on-demand to find out more:  https://lnkd.in/eX7bnUUY

#digitalpathology #drugdiscovery #pathologyreviews #datamanagement #drugdevelopment #GLP #nonGLP #datacapture #Webinar #PatholytixDCM

Congratulations to the entire Deciphex team on our double win at the Irish Medtech Awards! 🎉 We're absolutely thrilled to have been named Medtech Company of the Year and to receive the Digital Health Innovation of the Year award. 🏆🏆

This recognition means the world to us and is a testament to the hard work, dedication, and innovation that drives us every day. Thank you to the Irish Medtech Association, IDA Ireland, Enterprise Ireland, and everyone who has supported us on this incredible journey.

We couldn't have achieved this without our amazing team and partners. Here's to pushing the boundaries of medtech and digital health! 🚀 

#MedtechRising #IrishMedtechAwards


A few weeks ago, our research paper, "Synergies and Challenges in the Preclinical and Clinical Implementation of Pathology Artificial Intelligence Applications", was published. Are you curious about the key takeaways? Watch Max Qureshi share insights below in this ‘Authors Insights’ video from the Mayo Clinic!

📄 Access the full paper: https://lnkd.in/g5kQ5WjU

Discover the future of pathology with us! 🌟 #PathologyAI #Research #Innovation

📢 We are thrilled to announce the recent publication of a paper authored by our Chief Medical Officer, Prof. Runjan Chetty, and Senior Manager for Technical Integration & Support, James Johnson, on the implementation of digital pathology workflows.

In today's rapidly evolving healthcare landscape, digital pathology is proving to be a transformative technology. The paper presents a comprehensive management approach to successfully navigate the challenges associated with its implementation.

Key highlights from the paper include the importance of stakeholder engagement from hospital administration, IT, and laboratory management, as well as the necessity of developing a customised business case tailored to local needs. It emphasises the need to assess the impact of this "disruptive" technology on work habits and workflow and recommends planning for the selection of scanners and software that seamlessly integrate with the laboratory information system.

Additionally, the authors stress the criticality of service contracts and redundancy planning to mitigate potential disruptions due to scanner failure or breakdown. The paper also outlines a phased approach to pathologist management, including formal validation and ongoing monitoring.

We extend our warm congratulations to Prof. Runjan Chetty and James Johnson for their exceptional work on this paper. 🌟

This paper is essential reading for healthcare professionals considering the adoption of digital pathology. It offers practical insights to ensure a smooth transition into this innovative technology.

Access the full paper here: https://lnkd.in/eae3Zzbm

#DigitalPathology #HealthcareInnovation #MedicalTechnology #HealthTech


COM:DECIPHEX

Deciphex

name

homepage url

country

crunchbase url

employee count

sector

industry

monthly webtraffic

monthly webtraffic growth

stage

raised capital

Description

peer of

investor of

competitor of

Metrics